The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Changes and Possible Fundraising

25 May 2017 07:00

RNS Number : 1660G
Arden Partners plc
25 May 2017
 

 

Arden Partners plc

("Arden" or the "Company")

 

Directorate changes and possible fundraising

 

 

Directorate changes

 

Arden is pleased to announce that Donald Brown has been appointed to the Arden Board as Chief Executive Officer (designate) of the Company, subject to regulatory approval.

 

Donald Campbell Brown (aged 47) has more than 25 years' experience of working in the small and mid cap broking sector, most recently as a Managing Director at the Royal Bank of Canada for the last seven years. He previously held senior positions at Collins Stewart and Evolution Securities.

 

James Reed-Daunter, the current Chief Executive Officer, will formally step down from the role once regulatory approval of Donald Brown's appointment has been confirmed. Going forward, James Reed-Daunter will continue to serve as an Executive Director on the Arden Board and as a senior member of Arden's Equity Capital Market's team.

 

Additionally it is intended that, once regulatory approval of Donald Brown's appointment has been confirmed, Jonathan Keeling, Executive Deputy Chairman and Stephen Wassell, Chief Operating Officer, will both step down from the Arden Board. Both will remain with the Company in senior managerial positions, as Chairman of the Operations Committee and as Operations Director respectively.

 

Possible fundraising

 

Arden also announces today that it intends to conduct a placing of new ordinary shares in the Company to raise approximately £5.0 million (before expenses) (the "Fundraising"). This additional financial resource, once raised, will be used to strengthen the Company's capital reserves and allow it to continue to attract further senior hires and incremental teams into the business. A further announcement on the Fundraising will be made in due course.

 

Commenting on the proposed Board changes and the Fundraising Luke Johnson, Non-Executive Chairman of Arden, said:

 

"Arden is fortunate to have attracted a man of Donald's character and experience - he has remarkable market knowledge and a formidable network of institutional contacts. On behalf of the Board, I welcome him to the Company and look forward to working with him to grow the Arden business.

 

My sincere thanks go to James Reed-Daunter for his selflessness in identifying and driving this significant opportunity for the firm and I am also extremely grateful to Jonathan Keeling and Steve Wassell for their respective efforts and contributions whilst serving on the Arden Board.

 

I believe that a leaner, more nimble Board will enable the firm to react more swiftly to rapidly changing market conditions and to take advantage of future opportunities.

 

The Fundraising, once complete, will provide the Arden management with further financial flexibility with which to grow the Company."

 

Donald Brown has confirmed that there are no further disclosures to be made in accordance with paragraph (g) of Schedule 2 of the AIM Rules.

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

 

 

Enquiries:

 

Arden Partners plc

 

0121 423 8993

Steve Wassell - Company Secretary

 

 

GCA Altium - NOMAD to Arden Partners plc

0207 484 4040

Sam Fuller

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCOKQDPABKDAPB
Date   Source Headline
28th Apr 202210:15 amRNSOffer Update - Scheme of Arrangement - Effective
28th Apr 20227:30 amRNSSuspension - Arden Partners PLC
28th Apr 20227:00 amRNSNomad register change - Arden Partners Plc
27th Apr 20224:30 pmRNSOffer Update-Court Sanction, Scheme of Arrangement
27th Apr 20224:30 pmRNSOffer Update - Court Sanction of Scheme
21st Apr 20225:30 pmRNSInce Group
19th Apr 20222:00 pmRNSOffer Update – Extension of FCA approval
19th Apr 20222:00 pmRNSExtension of FCA Change of Control Approval
14th Apr 20227:00 amRNSOffer Update - Timetable for completion of Scheme
14th Apr 20227:00 amRNSOffer Update - Timetable for Completion of Scheme
12th Apr 202211:55 amRNSForm 8.5 (EPT/NON-RI)
11th Apr 20227:00 amRNSOffer update – Waiver of NOMAD condition
11th Apr 20227:00 amRNSOffer Update - Waiver of NOMAD Condition
8th Apr 20222:19 pmRNSPublication of Annual Report and Notice of AGM
7th Apr 20222:18 pmRNSHolding(s) in Company
7th Apr 20229:33 amRNSUpdate regarding the NOMAD condition
7th Apr 20227:00 amRNSUpdate Regarding the Nomad Condition
6th Apr 202211:41 amRNSForm 8.3 - Arden Partners plc
5th Apr 20227:00 amRNSAudited Results for the Year Ended 31 October 2021
18th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
15th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI) - AssetCo PLC
14th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 202210:20 amRNSForm 8.5 (EPT/NON-RI)
10th Mar 20229:48 amRNSForm 8.3 - Ince Group PLC
7th Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
3rd Mar 202211:55 amRNSForm 8.5 (EPT/NON-RI)
17th Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
11th Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
10th Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
9th Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
4th Feb 20221:03 pmRNSForm 8.5 (EPT/NON-RI)
2nd Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
1st Feb 202211:55 amRNSForm 8.5 (EPT/NON-RI)
27th Jan 20221:00 pmRNSForm 8.5 (EPT/NON-RI)
26th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
25th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
21st Jan 20227:00 amRNSApproval of the FCA condition
21st Jan 20227:00 amRNSFCA Approval of the Change of Control
20th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
19th Jan 20224:30 pmRNSResults of Arden court meeting & general meeting
19th Jan 20224:24 pmRNSResults of Court Meeting and General Meeting
18th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
17th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
13th Jan 202211:55 amRNSForm 8.5 (EPT/NON-RI)
20th Dec 20212:30 pmRNSPublication of Scheme Document
15th Dec 20217:00 amRNSExtension Of Irrevocable Undertakings
8th Dec 20218:00 amRNSExtension Of Irrevocable Undertakings
1st Dec 20212:03 pmRNSForm 8 (DD) - The Ince Group plc
30th Nov 202111:55 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.